Large-Scale Manufacturing of Safe and Efficient Retrovirus Packaging Lines for Use in Immunotherapy Protocols

Journal of Gene Medicine

Volumn 1, Issue 3, 1999, Pages 195-209

  Farson, Deborah ^a   McGuinness, Ryan ^a   Dull, Tom ^a   Limoli, Kay ^a   Lazar, Richard ^a   Jalali, Sayeh ^a   Reddy, Sridhar ^a   Pennathur Das, Rukmini ^a   Broad, David ^a   Finer, Mitchell ^a  

^a CELL GENESYS INC   (United States)

Author keywords

Large scale manufacture; Retrovirus vector; T lymphocyte

Indexed keywords

HUMAN ENDOGENOUS RETROVIRUS H; UNIDENTIFIED RETROVIRUS;

RECOMBINANT DNA;

ANIMAL; ARTICLE; BIOTECHNOLOGY; CD8+ T LYMPHOCYTE; CELL DIVISION; CELL LINE; ENDOGENOUS RETROVIRUS; FLOW CYTOMETRY; GENE VECTOR; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOLOGY; IMMUNOTHERAPY; METHODOLOGY; PHYSIOLOGY; RETROVIRUS; SAFETY; VIRUS REPLICATION;

ANIMALS; BIOTECHNOLOGY; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELL LINE; DNA, RECOMBINANT; ENDOGENOUS RETROVIRUSES; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; IMMUNOTHERAPY; RETROVIRIDAE; SAFETY; TRANSDUCTION, GENETIC; TRANSFECTION; VIRUS REPLICATION;

EID: 0033122122     PISSN: 1099498X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1521-2254(199905/06)1:3<195::aid-jgm31>3.0.co;2-%23     Document Type: Article

References (52)

1. Smith C. Retroviral vector-mediated gene transfer into hematopoietic cells: Prospects and issues. J Hematother 1992; 1: 155-166.
2. Culver K, Cornetta S, Rorgan R, et al. Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proc Natl Acad Sci U S A 1991; 19(89): 3155-3159.
3. Mann R, Mulligan RH, Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 1983; 33: 153-159.
4. Miller AD, Buttimore C. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol 1986; 6: 2895-2902.
5. Danos O, Mulligan RC. Safe and efficient generation of recombinant retroviruses with amphotropic and ecotropic host ranges. Proc Natl Acad Sci U S A 1988; 85: 6460-6464.
6. Bosselman R, Hsu R, Bruszewski J, et al. Replication-defective chimeric helper proviruses and factors affecting generation of competent virus: expression of Moloney murine leukemia virus structural genes via the metallothionein promoter. Mol Cell Biol 1987; 7: 1797-1806.
7. Markowitz D, Goff S, Bank A. A safe packaging line for gene transfer: Separating viral genes on two different plasmids. J Virol 1988; 62: 1120-1124.
8. Chakraborty AK, Zink MA, Hodgson CP. Transmission of endogenous VL30 retrotransposons by helper cells used in gene therapy. Cancer Gene Ther 1994; 1: 113-118.
9. Donahue RE, Kessler SW, Bodine D, et al. Helper virus induced T cell lymphoma in nonhuman primates after retroviral mediated gene transfer. J Exp Med 1992; 176: 1125-1135.
10. Kasid A, Morecki S, Aebersold P, et al. Human gene transfer: Characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man. Proc Natl Acad Sci U S A 1990; 87: 473-477.
11. Morecki S, Karson E, Cornetta K, et al. Retrovirus-mediated gene transfer into CD4+ and CD8+ human T cell subsets derived from tumor-infiltrating lymphocytes and peripheral blood mononuclear cells. Cancer Immunol Immunother 1991; 32: 342-352.
12. Cosset F-L, Takeuchi Y, Battini J-L, Weiss R, Collins MKL. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995; 69: 7430-7436.
13. Pear W, Nolan G, Scott M, Baltimore D. Production of high-titer helper-free retroviruses by transient transfection. Proc Natl Acad Sci U S A 1993; 90: 8392-8396.
14. Forestell SP, Dando JS, Chen J, et al. Novel retroviral packaging cell lines: complementary tropisms and improved vector production for efficient gene transfer. Gene Ther 1997; 4: 600-610.
15. Rigg JR, Chen J, Dando S, et al. A novel human amphotropic packaging cell line: High titer, complement resistence, and improved safety. Virology 1996; 218: 290-295.
16. Finer MH, Dull TJ, Qin L, Farson D, Roberts MR. kat: A high-efficiency retroviral transduction system for primary human T lymphocytes. Blood 1994; 83: 43-50.
17. Roberts MR, Qin L, Zhang D. Targeting of human immunodeficiency virus-infected cells by CD8+ T lymphocytes armed with universal T-cell receptors. Blood 1994; 84: 2878-2889.
18. Roberts MR, Cooke K, Tran A-C. Antigen-specific cytolysis by neutrophils and NK cells expressing chimeric immune receptors bearing ζ or γ signalling domains. J Immunol 1998; 161: 375-384.
19. McGuinness R, Ge Y, Patel S, et al. Anti-tumor activity of human T cells expressing the CC49-C chimeric immune receptor. Hum Gene Ther 1999; 10: 165-173.
20. Ott D, Friedrich R, Rein A. Sequence analysis of amphotropic and 10A1 murine leukemia viruses: Close relationship to mink cell focus-inducing viruses. J Virol 1990; 64: 757-766.
21. Battini J-L, Heard JM, Danos O. Receptor choice determinants in the envelope glycoproteins of amphotropic, xenotropic, and polytropic murine leukemia viruses. J Virol 1992; 66(3): 1468-1475.
22. Dubridge RB, Tang P, Hsia HC, et al. Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 1985; 7: 379-387.
23. Heinzel S, Krysan P, Calos M, Dubridge RB. Use of simian virus 40 replication to amplify Epstein-Barr virus shuttle vectors in human cells. J Virol 1988; 62: 3738-3746.
24. Lander MR, Chattopadhyay SK. A Mus dunni cell line that lacks sequences closely related to endogenous murine leukemia viruses and can be infected by ecotropic, amphotropic, xenotropic, and mink cell focus-forming viruses. J Virol 1984; 52: 695-698.
25. Happala DK, Robey WG, Oroszlan SD, Tsai WP. Isolation from cats of an endogenous type C virus with a novel envelope glycoprotein. J Virol 1985; 53: 827-833.
26. Wigler M, Sweet R, Sim G, et al. Transformation of mammalian cells with genes from prokaryotes and eukaryotes. Cell 1979; 16: 777-785.
27. Evans LH, Morrison RP, Malik FG, Portis J, Britt WJ. A neutralizing epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J Virol 1990; 64: 6176-6183.
28. Levine BL, Mosca JD, Riley JL, et al. Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation. Science 1996; 272: 1939-1943.
29. Kotani H, Newton PB, 3rd Zhang S, et al. Improved methods of retroviral vector transduction and production for gene therapy. Hum Gene Ther 1994; 5: 19-28.
30. Wilson CA, Eiden MB, Marsh JW. Quantitative micro P30 and reverse transcriptase assays for Moloney murine leukemia virus. J Virol Methods 1994; 109-118.
31. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning (A laboratory Manual): Cold Spring Harbor Laboratory, 1982.
32. O'Neill RR, Buckler CE, Theodore TS, Martin MA, Repaske R. Envelope and long terminal repeat sequences of a cloned infectious NZB xenotropic murine leukenia virus. J Virol 1985; 53: 100-106.
33. Kozak S, Kabat D. Ping-pong amplification of a retroviral vector achieves high-level gene expression: human growth hormone production. J Virol 1990; 64: 3500-3508.
34. Kashmiri S, Shu L, Padlan E, et al. Generation, characterization and in vivo studies of humanized anticarcinoma antibody CC49. Hybridoma 1995; 14: 461-473.
35. Larsson E, Kato N, Cohen M. Human Endogenous Proviruses. Curr Top Microbiol Immunol 1989; 148: 115-132.
36. Wilkinson DA, Freeman JD, Goodchild NL, Kelleher CA, Mager DL. Autonomous expression of RTVL-H endogenous retrovirus-like elements in human cells. J Virol 1990; 64: 2157-2167.
37. Wilkinson DA, Goodchild NL, Saxton TM, Wood S, Mager DL. Evidence for a functional subclass of the RTVL-H family of human endogenous retrovirus-like sequences. J Virol 1993; 67: 2981-2989.
38. Patience C, Takeuchi Y, Cosset F-L, Weiss RA. Packaging of endogenous retroviral sequences in retroviral vectors produced by murine and human packaging cells. J Virol 1998; 72: 2671-2676.
39. Dranoff G, Jaffe E, Lazenby A, et al. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity. Proc Natl Acad Sci USA 1993; 90: 3539-3543.
40. Stuhlmann H, Berg P. Homologous recombination of copackaged retrovirus RNAs during reverse transcription. J Virol 1992; 66(4): 2378-2388.
41. Hege KM, Broad DF, Roberts MR, et al. T cell gene therapy of colorectal cancer with autologous CC49-zeta gene-modified CD4 and CD8 T cells. Proc Amer Soc Clin Oncol 1998; 17: 428a.
42. Hatzoglou M, Hodgson CP, Mularo F, Hanson RW. Efficient packaging of a specific VL30 retroelement by Psi 2 cells which produce MoMLV recombinant retroviruses. Hum Gene Ther 1990; 1: 385-397.
43. Scadden DT, Fuller B, Cunningham JM. Human cells infected with retrovirus vectors acquire an endogenous murine provirus. J Virol 1990; 64: 424-427.
44. Lower R, Boller K, Hasenmaier B, et al. Identification of human endogenous retroviruses with complex mRNA expression and particle formation. Proc Natl Acad Sci U S A 1993; 90(May): 4480-4484.
45. Rudoll T, Phillips K, Lee S-W, et al. High efficiency retroviral vector mediated gene transfer into human peripheral blood CD4+ T lymphocytes. Gene Ther 1996; 3: 695-705.
46. Pollok KE, Hanenberg H, Noblitt TW, et al. High-efficiency gene transfer into normal and adenosine deaminase-deficient T lymphocytes is mediated by transduction on recombinant fibronectin fragments. J Virol 1998; 72: 4882-4892.
47. Bunnell BA, Muul LM, Donahue RE, Blasese RM, Morgan RA. High-efficiency retroviral-mediated gene transfer into human and nonhuman primate peripheral blood lymphocytes. Proc Natl Acad Sci USA 1995; 92: 7739-7743.
48. Riddell S, Greenberg P. Principles for adoptive T cell therapy of human viral diseases. Annu Rev Immunol 1995; 13: 545-586.
49. Shinnick T, Lerner R, Sutcliffe G. Nucleotide sequence of Moloney murine leukaemia virus. Nature 1981; 293(October 15): 543-548.
50. Pear W, Scott M, Nolan G. Methods for generating high titer, helper-free, retroviruses by transient transfection. Methods in Molecular Biology: Humana Press, 1997.
51. Markowitz D, Goff S, Bank A. Construction and use of a safe and efficient amphotropic packaging cell line. Virology 1988; 167(2): 400-406.
52. Miller A, Rosman. Improved retroviral vectors for gene transfer and expression. Biotechniques 1989; 7(9): 980-990.